Literature DB >> 24632711

Multiple roles of the coagulation protease cascade during virus infection.

Silvio Antoniak1, Nigel Mackman.   

Abstract

The coagulation cascade is activated during viral infections. This response may be part of the host defense system to limit spread of the pathogen. However, excessive activation of the coagulation cascade can be deleterious. In fact, inhibition of the tissue factor/factor VIIa complex reduced mortality in a monkey model of Ebola hemorrhagic fever. Other studies showed that incorporation of tissue factor into the envelope of herpes simplex virus increases infection of endothelial cells and mice. Furthermore, binding of factor X to adenovirus serotype 5 enhances infection of hepatocytes but also increases the activation of the innate immune response to the virus. Coagulation proteases activate protease-activated receptors (PARs). Interestingly, we and others found that PAR1 and PAR2 modulate the immune response to viral infection. For instance, PAR1 positively regulates TLR3-dependent expression of the antiviral protein interferon β, whereas PAR2 negatively regulates expression during coxsackievirus group B infection. These studies indicate that the coagulation cascade plays multiple roles during viral infections.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24632711      PMCID: PMC3999750          DOI: 10.1182/blood-2013-09-526277

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  97 in total

Review 1.  Protease-activated receptors: novel PARtners in innate immunity.

Authors:  V Shpacovitch; M Feld; N W Bunnett; M Steinhoff
Journal:  Trends Immunol       Date:  2007-10-30       Impact factor: 16.687

2.  Molecular mimicry between virus and host and its implications for dengue disease pathogenesis.

Authors:  Yee-Shin Lin; Trai-Ming Yeh; Chiou-Feng Lin; Shu-Wen Wan; Yung-Chun Chuang; Tan-Kuei Hsu; Hsiao-Sheng Liu; Ching-Chuan Liu; Robert Anderson; Huan-Yao Lei
Journal:  Exp Biol Med (Maywood)       Date:  2011-04-18

3.  The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome.

Authors:  Catharina Suharti; Eric C M van Gorp; Tatty E Setiati; Wil M V Dolmans; Robert J Djokomoeljanto; C Erik Hack; Cate Hugo ten; Jos W M van der Meer
Journal:  Thromb Haemost       Date:  2002-01       Impact factor: 5.249

4.  Modulation of airway smooth muscle tone by protease activated receptor-1,-2,-3 and -4 in trachea isolated from influenza A virus-infected mice.

Authors:  R S Lan; G A Stewart; P J Henry
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

5.  Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis.

Authors:  Leonie A Boven; Nathalie Vergnolle; Scot D Henry; Claudia Silva; Yoshinori Imai; Janet Holden; Kenneth Warren; Morley D Hollenberg; Christopher Power
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

6.  A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages.

Authors:  Yu Zhou; Xu Wang; Manqing Liu; Quan Hu; Li Song; Li Ye; Dunjin Zhou; Wenzhe Ho
Journal:  Immunology       Date:  2010-07-16       Impact factor: 7.397

7.  Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

Authors:  Thomas W Geisbert; Lisa E Hensley; Peter B Jahrling; Tom Larsen; Joan B Geisbert; Jason Paragas; Howard A Young; Terry M Fredeking; William E Rote; George P Vlasuk
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

8.  Crosstalk between coagulation and inflammation during Dengue virus infection.

Authors:  Alejandra Huerta-Zepeda; Carlos Cabello-Gutiérrez; Jorge Cime-Castillo; Verónica Monroy-Martínez; Maria Eugenia Manjarrez-Zavala; Margarita Gutiérrez-Rodríguez; Raúl Izaguirre; Blanca H Ruiz-Ordaz
Journal:  Thromb Haemost       Date:  2008-05       Impact factor: 5.249

9.  Tropism-modification strategies for targeted gene delivery using adenoviral vectors.

Authors:  Lynda Coughlan; Raul Alba; Alan L Parker; Angela C Bradshaw; Iain A McNeish; Stuart A Nicklin; Andrew H Baker
Journal:  Viruses       Date:  2010-10-13       Impact factor: 5.818

10.  Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis.

Authors:  Fatma Berri; Guus F Rimmelzwaan; Michel Hanss; Emmanuel Albina; Marie-Laure Foucault-Grunenwald; Vuong B Lê; Stella E Vogelzang-van Trierum; Patrica Gil; Eric Camerer; Dominique Martinez; Bruno Lina; Roger Lijnen; Peter Carmeliet; Béatrice Riteau
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

View more
  76 in total

1.  Microvesicle Tissue Factor Activity and Interleukin-8 Levels are Associated with Mortality in Patients with Influenza A/H1N1 Infection.

Authors:  Matthew T Rondina; Kohei Tatsumi; Julie A Bastarache; Nigel Mackman
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

Review 2.  Interactions of viruses and the humoral innate immune response.

Authors:  Bailey E Maloney; Krishani Dinali Perera; Danielle R D Saunders; Naemi Shadipeni; Sherry D Fleming
Journal:  Clin Immunol       Date:  2020-02-04       Impact factor: 3.969

Review 3.  Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.

Authors:  Jens J Posma; Steven P Grover; Yohei Hisada; A Phillip Owens; Silvio Antoniak; Henri M Spronk; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

4.  Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.

Authors:  Yuichi Kamikubo; G Loredana Mendolicchio; Antonella Zampolli; Patrizia Marchese; Andrea S Rothmeier; Jennifer Nagrampa Orje; Andrew J Gale; Sriram Krishnaswamy; András Gruber; Henrik Østergaard; Lars C Petersen; Wolfram Ruf; Zaverio M Ruggeri
Journal:  Blood       Date:  2017-07-20       Impact factor: 22.113

5.  Myeloid cell-synthesized coagulation factor X dampens antitumor immunity.

Authors:  Claudine Graf; Petra Wilgenbus; Sven Pagel; Jennifer Pott; Federico Marini; Sabine Reyda; Maki Kitano; Stephan Macher-Göppinger; Hartmut Weiler; Wolfram Ruf
Journal:  Sci Immunol       Date:  2019-09-20

6.  Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice.

Authors:  Silvio Antoniak; Kohei Tatsumi; Michael Bode; Swetha Vanja; Julie C Williams; Nigel Mackman
Journal:  J Innate Immun       Date:  2016-11-08       Impact factor: 7.349

Review 7.  Targeting clotting proteins in cancer therapy - progress and challenges.

Authors:  Wolfram Ruf; Andrea S Rothmeier; Claudine Graf
Journal:  Thromb Res       Date:  2016-04       Impact factor: 3.944

Review 8.  Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke.

Authors:  Charles C Esenwa; Mitchell S Elkind
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

9.  Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice.

Authors:  S Antoniak; K Tatsumi; Y Hisada; J J Milner; S D Neidich; C M Shaver; R Pawlinski; M A Beck; J A Bastarache; N Mackman
Journal:  J Thromb Haemost       Date:  2016-04-05       Impact factor: 5.824

Review 10.  Tissue factor, protease activated receptors and pathologic heart remodelling.

Authors:  Silvio Antoniak; Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Thromb Haemost       Date:  2014-08-07       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.